FDA NDC Directory · JSON-LD · Markdown

Atazanavir

NDC 42385-920 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerLaurus Labs Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA212579
Dosage form / routeCAPSULE · ORAL
Active ingredientsATAZANAVIR SULFATE (150 mg/1)
Marketing started20210430
Package count2

External sources

Source: openFDA. Public-domain (CC0).